WO2025257801 - HEME-BINDING PROTEIN FOR THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY (IRI)
National phase entry is expected:
Publication Number
WO/2025/257801
Publication Date
18.12.2025
International Application No.
PCT/IB2025/056063
International Filing Date
13.06.2025
Title **
[English]
HEME-BINDING PROTEIN FOR THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY (IRI)
[French]
PROTÉINE DE LIAISON À L'HÈME POUR LE TRAITEMENT D'UNE LÉSION D'ISCHÉMIE-REPERFUSION (IRI)
Applicants **
CSL INNOVATION PTY LTD
MEDIZINISCHE HOCHSCHULE HANNOVER
Inventors
IMMENSCHUH, Stephan
NAKAGIRI, Tomoyuki
KUEHNEMUTH, Benjamin
Priority Data
24181904.4
13.06.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2563 | |
| EPO | Filing, Examination, Granting | 13063 | |
| Japan | Filing, Examination, Granting | 2401 | |
| South Korea | Filing, Examination, Granting | 2439 | |
| USA | Filing, Examination, Granting | 5140 |
Total:
25,606
Contact Us
Abstract[English]
The present disclosure relates generally to heme-binding proteins and compositions thereof, and their use in the treatment of ischemia-reperfusion injury, in particular ischemia-reperfusion injury-mediated inflammation.[French]
La présente divulgation concerne de manière générale des protéines de liaison à l'hème et des compositions de celles-ci, et leur utilisation dans le traitement d'une lésion d'ischémie-reperfusion, en particulier d'une inflammation médiée par une lésion d'ischémie-reperfusion.